Ethics, One Health approaches, and SDGs: conference lessons for an emerging field.

One Health ethics is an emerging field that has gained traction since its origin in approximately 2015. This article builds upon the insights shared during a panel discussion on at the 28th Annual International Sustainable Development Research Society Conference. The conference, themed aimed to advance and expand recent knowledge in the field.

The Prospect of Artificial Intelligence-Supported Ethics Review.

The burden of research ethics review falls not just on researchers, but also on those who serve on research ethics committees (RECs). With the advent of automated text analysis and generative artificial intelligence (AI), it has recently become possible to teach AI models to support human judgment, for example, by highlighting relevant parts of a text and suggesting actionable precedents and explanations. It is time to consider how such tools might be used to support ethics review and oversight.

Community Engagement, Equity, and Cross-Sector Public Health Practice.

In this topical review, we integrate 3 concepts-public health practice, community engagement, and cross-sector governance-to consider the following question: What is the underlying relationship between public health and cross-sector governance according to which the field can understand the role of community engagement in achieving health equity? We begin with an overview of public health practice and the practice of community engagement. Next, we position these practices in the broader turn toward cross-sector governance. The integration of these themes reveals that common tools for community engagement fail to address questions about how services should be funded, how resources should be distributed, and which members of the community have a claim to services.

[Why Men Choose for Concealment and Against Disclosure of their Depressive Illness? A Qualitative Study].

Objective: The qualitative study aims to explore reasons and occations for concealment in male participants with depression.

Methods: Five focus groups with 16 men were analysed via Qualitative Content Analysis.

Results: Four motives of concealment have been explored: 1.

Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2-T3 Disease.

Selected patients with early-stage melanoma have a "hidden high risk" of poor oncologic outcomes. They might benefit from clinical trials, and ultimately, if warranted by trial results, judicious everyday use of adjuvant therapy. A promising tool to identify these individuals is the immunoprint assay.